 role etoposid treatment carcinoma unknown primari site patient carcinoma pdc adenocarcinoma pda unknown primari site compris patient carcinoma unknown primari site patient neoplasm respons combin chemotherapi minor curabl tumor between patient combin chemotherapi cisplatin vinblastin bleomycin pvb doxorubicin thirty-eight patient treatment complet respond CR long-term disease-fre survivor time treatment patient synerg cisplatin great activ sever neoplasm germ cell tumor seventeen patient pdc unknown primari site salvag therapi etoposid cisplatin pvb patient partial respons PR median respons durat month rang month thirty-two patient pdc cisplatin combin initi treatment eighteen evalu patient patient CR seven patient disease-fre month complet therapi etoposid activ drug treatment pdc unknown primari site preliminari result initi treatment etoposid cisplatin combin result equival superior pvb